The Accreditation for Cardiovascular Excellence (ACE) is the exclusive international provider of interventional cardiology, electrophysiology, congenital heart disease and endovascular catheterization lab accreditation, and a valuable resource for asserting a commitment to the highest standards of care in invasive cardiology. Since 2011, (ACE) has reviewed the structure, internal processes, patient safety practices, and clinical outcomes of cardiac catheterization laboratories. To achieve ACE accreditation, facilities must demonstrate compliance with rigorous ACE quality standards that are based on published guidelines, expert consensus documents, and scientific data.  
 

Non-calcified arterial plaque is associated with diabetes, high systolic blood pressure and elevated “bad” cholesterol levels in asymptomatic individuals, according to a new study published online in the journal Radiology.

The Valley Hospital has been selected as the United States Coordinating Center for the international PRAETORIAN trial analyzing implantable cardioverter-defibrillators (ICDs). The trial will compare traditional ICDs with a newer model that may reduce the risk of complications associated with these otherwise life-saving devices.

Cincinnati Children’s Hospital Medical Center (CCHMC) has evaluated synthetic magnetic resonance imaging (MRI) on pediatric cases to study and clinically validate its use on children. Results from the first part of the evaluation, which used SyMRI software, shows the synthetic images are diagnostically satisfactory in comparison with conventional sequences.


According to a new report from BCC Research, the global market for disposable medical sensors grew to $4.2 billion in 2014 from $3.8 billion in 2013. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 10.2 percent from 2014 to 2019, reaching $6.8 billion in 2019.


Subscribe Now